menu search

Moderna rockets higher as vaccine offers glimpse of 'new paradigm ' in cancer treatment

Moderna shares rose by almost 20% overnight in the US an experimental cancer vaccine based on its messe...

December 14, 2022, 3:27 am

Poolbeg pharma targets first half of next year for first trial of oral diabetes/anti-obesity drug

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has exclusively licensed specialist microencapsulation or nanoencapsulation developed by a company...

December 14, 2022, 2:40 am

Moderna, merck stocks boosted amid joint cancer vaccine trials

Yahoo Finance health correspondent Anjalee Khemlani joins the Live show to review Moderna and Merck shares following positive results seen in their jo...

December 13, 2022, 4:52 pm

Melanoma vaccine data should make investors more positive on moderna, says jefferies' michael yee

Michael Yee, Jefferies, joins 'Closing Bell' to discuss Moderna popping on strong Melanoma vaccine data...

December 13, 2022, 4:47 pm

: nursing home residents and staff are not up to date on covid-19 vaccines

Vaccination rates dropped after mandates, so fewer people have up-to-date boosters. Read Full Story The...

December 13, 2022, 4:42 pm

Moderna soars on cancer vaccine news: here's what to watch going forward - moderna (nasdaq:mrna)

Moderna, Inc MRNA gapped up 13% to start the trading day on Tuesday and was skyrocketing an additional 12% intraday after announcing that its Merck & ...

December 13, 2022, 3:33 pm

Encouraging trial data sends moderna stock soaring

Moderna Inc (NASDAQ:MRNA) is up 23.6% at $204.04 at last check, after a mid-stage trial showed the combination of its experimental melanoma v...

December 13, 2022, 2:18 pm

Is novavax stock a buy on a vaccines rally following bullish moderna news?

Is Novavax stock a buy after vaccine stocks surged on bullish news from Moderna? Is NVAX stock a buy ri...

December 13, 2022, 2:04 pm

Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the disease

"Now, we are an oncology company," Moderna CEO Stéphane Bancel told Insider....

December 13, 2022, 1:28 pm

Moderna shares get a boost from merck vaccine combo

Moderna Therapeutics Inc (NASDAQ:MRNA) shares rallied after the biotechnology firm told investors that a trial that combined its investigational cance...

December 13, 2022, 12:49 pm

Moderna stock jumped 25% on a ‘big day for patients'

Shares of Moderna Inc (NASDAQ: MRNA) are up nearly 25% on Tuesday after the biotech firm said its experimental v...

December 13, 2022, 12:17 pm

Moderna will apply ‘same intensity' for cancer vaccine as it did for covid, ceo says

Moderna CEO Stéphane Bancel speaks with Yahoo Finance's Anjalee Khemlani about the company's MRNA skin cancer v...

December 13, 2022, 12:00 pm

Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial

The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' risk...

December 13, 2022, 11:55 am

Moderna and merck team-up to fight melanoma

Vaccine-maker Moderna has partnered with the biopharmaceutical company Merck to create an effective tre...

December 13, 2022, 10:49 am

Why moderna stock is skyrocketing today

Moderna's personalized cancer vaccine program just received a big boost....

December 13, 2022, 10:32 am

Is moderna stock a buy on a bullish update for its cancer vaccine?

Is Moderna stock a buy after the company offered a promising update for its cancer vaccine? Is MRNA sto...

December 13, 2022, 9:59 am

Moderna (mrna) stock soars on cancer vaccine news

Moderna (NASDAQ: MRNA ) stock is rising higher on Tuesday following the release of data from a Phase 2B cancer v...

December 13, 2022, 9:31 am

Moderna ceo stéphane bancel on promising new data for mrna cancer vaccine

Moderna CEO Stéphane Bancel joins CNBC's 'Squawk Box' to discuss promising new data surrounding its experimental cancer v...

December 13, 2022, 8:50 am

Merck, moderna say mrna vaccine and keytruda lowers the risk of death in melanoma patients

Merck & Co. Inc. MRK, +0.17% and Moderna Inc. MRNA, -6.89% said Tuesday that their experimental mRNA-based cancer v...

December 13, 2022, 7:34 am

Why merck's $250 million investment in moderna may have just paid off

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results could sp...

December 13, 2022, 7:00 am


Search within

Pages Search Results: